Literature DB >> 989256

Intrathecal pharmacotherapy in coma.

M Ogashiwa, K Takeuchi.   

Abstract

A study was made of intrathecal infusion as a route for administration of drugs for the CNS. We recognize the presence of blood brain and CSF brain barriers. CDP-choline was used as the brain activator, and the effect of the intrathecally infused drug was investigated clinically. Fifteen patients with disturbances of consciousness due to primary cerebral lesions received a total of 39 intrathecal infusions of CDP-choline, and were examined neurologically and electroencephalographically before and after treatment.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 989256     DOI: 10.1007/bf01405861

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  3 in total

1.  [TREATMENT OF HEAD INJURIES WITH INTERMEDIATE SUBSTANCES OF THE METABOLIC CYCLE OF THE BRAIN. 1. THE USE OF CDP-CHOLINE].

Authors:  H MIYAKE; I HAYAKAWA; K TAKAKURA
Journal:  No To Shinkei       Date:  1964-10

2.  ELECTROENCEPHALOGRAPHIC CHANGES IN ACUTE CEREBRAL ANOXIA FROM CARDIAC OR RESPIRATORY ARREST.

Authors:  J M HOCKADAY; F POTTS; E EPSTEIN; A BONAZZI; R S SCHWAB
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1965-05

3.  [Distribution and metabolism of CDP-choline].

Authors:  Y Yonekawa; K Seta
Journal:  No To Shinkei       Date:  1970-07
  3 in total
  1 in total

Review 1.  Role of Citicoline in the Management of Traumatic Brain Injury.

Authors:  Julio J Secades
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.